Standardizing PCR testing throughout your care continuum provides patients with the quality they deserve no matter where and when they seek care.

With customizable capacity and a menu of 20+ FDA cleared tests, Cepheid’s GeneXpert® System can improve clinical outcomes, operational efficiencies, and financial metrics in a health system.

 

 

Clinical

 

 

Operational

 

Financial

Healthcare-Associated Infections

Virus
 
Bed
 
Finance

MRSA
C. difficile
Carba-R
VRE

 

69-85% decrease
in infection rate1

 

 

 

 

33% decrease
in isolation day2

 

 

 

 

$2.4M savings
on cost of care3

 

 

Respiratory Infections

Target
 
Mask
 
Finance

Flu
RSV
Strep A
COVID-19

 

18% increase
in accurate test results reduced empiric treatment4

 

 

 

 

387 days decrease
in unnecessary droplet precautions5

 

 

 

 

$400K savings
on bed costs and Tamiflu® usage5

 

 

Women's & Sexual Health

Bottle
 
Clock
 
Finance

Chlamydia
Gonorrhea
Trichomoniasis
GBS

 

12.5% increase
in appropriate initial treatment6

 

 

 

 

2 hours per day reduction
in staff time spent on phone calls with anxious patients7

 

 

 

 

$37K savings
on additional testing, antimicrobial utilization and ED readmission6

 

 

References

1. Cepheid. Ephraim McDowell Regional Medical Center improves adherence to optimized testing protocols for Clostridium difficile resulting in lower C. difficile rates and decreased patient time in isolation. (0664-03) [Impact Brief] http://cepheidevents.com/Case-Studies/Cepheid_Ephraim%20McDowell_Case%20Study_US_0664-03.pdf
2. Cepheid. Leading-Edge Molecular Testing Drives Improved Process and Enhanced Patient Care. (0566-01) [Impact Brief] http://cepheidevents.com/Case-Studies/Wenatchee%20Impact%20Brief%200566-01.pdf
3. Cepheid. Five Campus Health System Fulfills Senior Management Challenge to Dramatically Reduce HAIs (0349-03) [Impact Brief] http://cepheidevents.com/Case-Studies/Cone_HAI_Study.pdf
4. Cepheid. Millard Henry Clinic (MHC) improves treatment accuracy through the use of Xpert® Xpress Flu/RSV and antimicrobial stewardship while maintaining efficient patient flow during a very busy flu season. (0716-01) [Impact Brief] https://p.widencdn.net/fhd4k4/Cepheid-Millard-Henry-Clinic-Case-Study-US-IVD-0716-English
5. Cepheid. Einstein Medical Center Montgomery sees significant reduction in oseltamivir (Tamiflu®) usage and improved length of stay through the use of real-time PCR testing with Xpert® Flu/RSV XC. (0724-01.A) [Impact Brief] https://p.widencdn.net/qvoang/Cepheid-Einstein-Medical-Center-Case-Study-US-IVD-0724-English
6. Cepheid. Mercy Health Saint Mary’s in Grand Rapids, MI reduces time to result and improves treatment accuracy through the use of Xpert® CT/NG and antimicrobial stewardship (0629-01) [Impact Brief] http://cepheidevents.com/Case-Studies/Cepheid_Mercy_Health_Case_Study_US_0629_01.pdf
7. Cepheid. Women’s Health Group reduces time to result and improves treatment accuracy through the use of Xpert® CT/NG and antimicrobial stewardship (0700-01) [Impact Brief] http://cepheidevents.com/Case- Studies/ Cepheid_The_Womens_Health_Group_Case_Study_US_0700_01.pdf
Projections and realized results are specific to the institution where they were obtained and may not reflect the results achievable at other institutions. Doesn't need an asterisk or other symbol. Statement can stand on its own.

Request Information

In submitting this form, you agree to be contacted by Cepheid to receive information on products, goods, and services, which may include similar products, goods, or services from our affiliates. Consent may be withdrawn at any time. For additional information about how we handle your personal data, please review our online privacy policy.